News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings Shelley Wood January 19, 2017
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr. October 30, 2016